-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vck7bDsPMWqECx5zkHlGju+h5FaIm5jv2akmdU7t3yGfBHrnE8voyXgFCHnQZbEZ y4vCvjaNJy4ZSBphp0qD1Q== 0001237899-10-000015.txt : 20100204 0001237899-10-000015.hdr.sgml : 20100204 20100204183311 ACCESSION NUMBER: 0001237899-10-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100202 FILED AS OF DATE: 20100204 DATE AS OF CHANGE: 20100204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCorkle Douglas S CENTRAL INDEX KEY: 0001403178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 10575250 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-02-02 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001403178 McCorkle Douglas S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller and Asst Treasur Common Stock 2010-02-02 4 M 0 4000 11.64 A 4000 D Common Stock 2010-02-02 4 S 0 4000 28 D 0 D Common Stock 2010-02-02 4 M 0 1875 9.49 A 1875 D Common Stock 2010-02-02 4 S 0 1875 28 D 0 D Common Stock 3424 I By 401(k) Plan Incentive Stock Option (right to buy) 9.49 2010-02-02 4 M 0 1875 D 2014-12-15 Common Stock 1875 0 D Incentive Stock Option (right to buy) 11.64 2010-02-02 4 M 0 4000 D 2015-12-19 Common Stock 4000 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Douglas S. McCorkle 2010-02-03 -----END PRIVACY-ENHANCED MESSAGE-----